Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Friday, 1 February 2019, 07:00 HKT/SGT
Share:
    

Source: Canbiola, Inc.
Canbiola Launches Revolutionary CBD Wellness Solution for Tissue Healing and Chronic Pain
- Expected to accelerate revenue growth in 2019
- Commits to 1,650 SAM units in 2019, with each potentially generating $14,210 revenue per year

Hicksville, NY, Feb 1, 2019 - (ACN Newswire) - via NewMediaWire -- Canbiola, Inc. (OTCQB: CANB) ("Canbiola"), a developer, manufacturer and seller of a variety of Cannabidiol (Hemp) based products such as oils, creams, moisturizers, chews, isolate, gel caps, concentrate and water, announced today the launch and availability of a revolutionary Sustained Acoustic Medicine ("SAM") wellness solution. SAM, along with its proprietary CBD Gel Capture Patches, is proven in accelerating tissue healing and chronic pain reduction and is reimbursable by health insurance companies.

The SAM Pro 2.0 is the first and only FDA cleared wearable low-intensity ultrasound device delivering multi-hour treatment to accelerate healing and improve function for musculoskeletal injuries (muscle, tendon, ligament) and reducing chronic pain (without opioid pain medication).

Canbiola and its Duramed subsidiary have attained exclusive distribution of SAM Pro 2.0 in the United States for no-fault insurance. Under its agreement with Sam International and ZetrOZ Systems, Canbiola is committed to purchasing 100 units per month starting in January and ramping to 150 units per month by June, for a total of 1,650 units for 2019.

Canbiola's marketing strategy is to provide equipment and services to both medical offices as well as direct to consumer. We are presently billing and collecting from the insurance companies at $58 per day per unit. Given discussions with the medical community, including doctors and patients, the Company believes the patient will use the Sam unit and pads for an average of 35 days per cycle and that each unit will cycle an estimated 7 times per year. Thus, each unit potentially provides $14,210 in gross rental revenue per year.

Canbiola Chief Executive Officer Marco Alfonsi, commented, "We are very excited in achieving this milestone of launching a revolutionary solution that addresses a much-needed void in the market to accelerate tissue healing and chronic pain reduction. Our proprietary CBD gels coupled with the unique SAM delivery system, which we have exclusive U.S. rights within no-fault insurance to, will potentially drive our acceleration of both revenues and gross margins over the next twelve months."

About Canbiola, Inc.
Canbiola, Inc. (OTCQB: CANB) is a developer, manufacturer and seller of a variety of Cannabidiol (Hemp) based products such as oils, creams, moisturizers, chews, vapes, isolate, gel caps, concentrate and water. Canbiola has developed its own line of proprietary products as well as seeking synergistic value through acquisitions in the CBD and the medical cannabis industry. Cannabis is currently federally illegal and has legalized for medical purposes in some form in a limited number of states, but pure CBD products are legal in all 50 states. For more information about Canbiola, Inc., please visit: https://canbiola.com

Canbiola Investor Relations
Email : [email protected]
Telephone:+1-516-95-9544
Like us:Twitter + Facebook

Forward Looking Statements
Forward-looking statements and risks and uncertainties discussed in this letter contain forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, including but not limited to, risks and uncertainties associated with, among other things, the impact of economic, competitive, and other factors affecting our operations, markets, products, and performance.



Feb 1, 2019 07:00 HKT/SGT
Topic: Press release summary
Sectors: Daily Finance, BioTech, HealthCare, Alternatives, Local, Local Business
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2019 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.


Multimedia
View Image
 

Latest Press Releases
MHIEC Receives Order to Refurbish the Hiroshima Naka Waste to Energy Plant  
Aug 20, 2019 10:09 HKT/SGT
IVD Medical announces 2019 Interim Results; Profit surges 897.3% to RMB 350 million  
Aug 20, 2019 09:55 HKT/SGT
Four HKTDC August fairs and ICMCM draw to a close  
Aug 19, 2019 20:00 HKT/SGT
Sino-US trade talks resume but outcome still uncertain  
Aug 19, 2019 20:00 HKT/SGT
Student Group Looks to Hold Night Festival to Help Increase Tourism to Kouri Island, Okinawa  
Aug 19, 2019 18:00 HKT/SGT
JCB partners with EVO Payments to enable JCB card acceptance for merchants in the UK and Ireland  
Aug 19, 2019 16:00 HKT/SGT
New Combustor Center for Manufacturing Aero Engine Parts to be Established within MHI's Nagasaki Shipyard & Machinery Works  
Aug 19, 2019 11:49 HKT/SGT
China Medical System Holdings Limited 2019 Interim Results Announcement  
Aug 16, 2019 21:19 HKT/SGT
Toyota Yaris WRC Ready to Master the Varied Roads of Germany  
Aug 16, 2019 19:13 HKT/SGT
Hengdeli Announces 2019 Interim Results  
Aug 16, 2019 19:12 HKT/SGT
More Press release >>
 Events:
More >>
 News Alerts
Copyright © 2019 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 6859 8575

Connect With us: